Company Filing History:
1 out of 1 
1 out of 1 
1 out of 9 Years Active: 2012
Title: Aiping Yu: Innovator in Medical Biotechnology
Introduction
Aiping Yu is a distinguished inventor based in Beijing, China, recognized for his contributions to the field of medical biotechnology. With two patents to his name, Yu continues to impact the development of innovative therapeutic solutions.
Latest Patents
Aiping Yu's latest patents reflect his expertise in creating advanced fusion proteins with significant medical applications. His first patent, titled "Bifunctional fusion protein with thrombolytic and anticoagulant activities and uses thereof," focuses on a fusion protein composed of thrombolytic and anticoagulant proteins linked by a peptide that can be cleaved by blood coagulation factors. The innovation enhances the efficacy of treatments related to blood clotting disorders. His second patent, "Preparation of low bleeding anticoagulant fusion protein and its use," describes an anticoagulant fusion protein that is cleavable by factors XIa and Xa or thrombin and factor Xa, along with its preparation methods and medicinal applications, demonstrating a significant advancement in anticoagulation therapies.
Career Highlights
Throughout his career, Aiping Yu has been associated with prominent research institutions and companies. He has worked at the Institute of Radiation Medicine, part of the Academy of Military Medical Sciences, and Beijing Sanly Sci-tech Development Inc. Ltd., where he has concentrated on innovative biomedical research. His contributions are a testament to his commitment to advancing medical science.
Collaborations
Yu has collaborated with esteemed colleagues, including Zuze Wu and Chuanling Zhang, enhancing the scope and impact of his research. These collaborations indicate a cooperative spirit in the scientific community, which is vital for fostering innovation.
Conclusion
Aiping Yu's work signifies a valuable contribution to the field of medical innovations, especially in creating fusion proteins with diverse therapeutic applications. His ongoing research and developments continue to push the boundaries of biotechnology, promising a brighter future in medical treatments.